Benign Prostatic Hyperplasia Devices Market Expected to Rise by a CAGR of 25 41% by 2026 globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Search jobs 10-Feb-2021 Vascular Surgery and Endovascular Procedures Market Size 2021 Industry Innovation, Share, Size, Future Trends, Growth Opportunities, Key Players and COVID-19 Impact Analysis 2027
“Global
Vascular Surgery and Endovascular Procedures Market–Industry Trends, Analysis and Forecast to 2027” New Research Report Added to Databridgemarketresearch. This report is provided with complete 350 pages,220 list of tables, 60 no of figures and also infographics. The report provides CAGR values along with its fluctuations for the specific forecast period. The Vascular Surgery and Endovascular Procedures Market report has been generated by taking into thought several aspects of marketing research and analysis that can be listed as market size estimations, market dynamics, company & market best practices, entry level marketing strategies, positioning and segmentations, competitive landscaping, opportunity analysis, economi
Medeon Announces Positive Clinical Results for XFLO Minimally Invasive BPH Treatment Device
News provided by
Share this article
Share this article
TAIPEI, Jan. 27, 2021 /PRNewswire/ Medeon Biodesign, Inc. (TPEx: 6499), a Taiwan publicly traded medical device company, is pleased to announce positive interim results of the EXPANDER-1 Clinical Study for its flagship product the XFLO™ Expander System, an innovative, minimally invasive Benign Prostatic Hyperplasia (BPH) treatment solution. XFLO offers a reversible and office-based treatment option for patients who are seeking immediate relief from lower urinary tract symptoms (LUTS) caused by BPH without compromising sexual function.
The XFLO Expander System is designed to provide patients with immediate relief BPH-related symptoms (LUTS) by placing an expander implant in the prostatic urethra using a low-profile delivery catheter and a standard flexible cystoscope. The XFLO Expander System opens the prostatic urethra that is na